New HIV vaccine could expose latent virus, kill it

CHUKWUMA MUANYA | April 15, 2019

article image
Antiretroviral therapy may soon be obsolete, as scientists have successfully used immune cells to kick the dormant form of Human Immuno-deficiency Virus (HIV) out of its hiding place and destroy it. The findings may soon lead to an HIV vaccine. With the help of antiretroviral therapy, over half of these people now have a very low level of the virus. This means that they can no longer transmit it to other people. Antiretroviral therapy can keep HIV in check so well that the virus is near-undetectable in the blood. However, HIV continues to “live” in latent form, so people with it must keep taking the medications to prevent it from flaring up. 

Spotlight

CareCulture Health Partners

CareCulture Health Partners is a privately-owned emergency, hospital medicine, and urgent care management services company headquartered in Dallas, Texas. We transform emergency department, urgent care, and hospitalist teams into high-functioning, clinician-driven groups by empowering clinicians, aligning with your facility's goals, and establishing a culture of accountability and lateral service. We offer administrative, clinical, and operational management services that transform and improve emergency departments, urgent care centers, and hospitalist programs.

OTHER ARTICLES
MEDICAL

Better Purification and Recovery in Bioprocessing

Article | August 2, 2021

In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross is both voluminous and various. And the biotherapeutic gold, unlike real gold, is corruptible. That is, it can suffer structural damage and activity loss. When discarding the dross and collecting the gold, bioprocessors must be efficient and gentle. They must, to the extent possible, eliminate contaminants and organic debris while ensuring that biotherapeutics avoid aggregation-inducing stresses and retain their integrity during purification and recovery. Anything less compromises purity and reduces yield. To purify and recover biotherapeutics efficiently and gently, bioprocessors must avail themselves of the most appropriate tools and techniques. Here, we talk with several experts about which tools and techniques can help bioprocessors overcome persistent challenges. Some of these experts also touch on new approaches that can help bioprocessors address emerging challenges.

Read More
DIAGNOSTICS

Making Predictions by Digitizing Bioprocessing

Article | April 20, 2021

With advances in data analytics and machine learning, the move from descriptive and diagnostic analytics to predictive and prescriptive analytics and controls—allowing us to better forecast and understand what will happen and thus optimize process outcomes—is not only feasible but inevitable, according to Bonnie Shum, principal engineer, pharma technical innovation, technology & manufacturing sciences and technology at Genentech. “Well-trained artificial intelligence systems can help drive better decision making and how data is analyzed from drug discovery to process development and to manufacturing processes,” she says. Those advances, though, only really matter when they improve the lives of patients. That’s exactly what Shum expects. “The convergence of digital transformation and operational/processing changes will be critical for the facilities of the future and meeting the needs of our patients,” she continues. “Digital solutions may one day provide fully automated bioprocessing, eliminating manual intervention and enabling us to anticipate potential process deviations to prevent process failures, leading to real-time release and thus faster access for patients.” To turn Bioprocessing 4.0 into a production line for precision healthcare, real-time release and quickly manufacturing personalized medicines will be critical. Adding digitization and advanced analytics wherever possible will drive those improvements. In fact, many of these improvements, especially moving from descriptive to predictive bioprocessing, depend on more digitization.

Read More

Spotlight

CareCulture Health Partners

CareCulture Health Partners is a privately-owned emergency, hospital medicine, and urgent care management services company headquartered in Dallas, Texas. We transform emergency department, urgent care, and hospitalist teams into high-functioning, clinician-driven groups by empowering clinicians, aligning with your facility's goals, and establishing a culture of accountability and lateral service. We offer administrative, clinical, and operational management services that transform and improve emergency departments, urgent care centers, and hospitalist programs.

Events